Bioengineered solutions for better immunotherapies

Cell-based immunotherapies, the use of one’s own immune cells to boost immunity against certain diseases has tremendous potential. For example, genetically modified T-cells have been successfully used against blood cancers, but the same approach falls short against solid cancers. Based on our believe that cell-based immunotherapies can be further optimized for efficiency and efficacy through addressing the mechanical and physicals cues that suppress immune potency. We are bioengineering solutions to better expand fitter T-cells to overwhelm cancer.